Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Bartoletti

Showing results (151-160 of 209) with videos related to

Pageof 21
Sort By:
Gynecologic Oncology|March 25, 2023
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trialLucia Musacchio, Margherita Turinetto, Laura Arenare, et al.
Antimicrobial Resistance and Infection Control|May 11, 2026
Clinical and cost benefit of rapid molecular screening for carbapenem-resistant organisms: a seven-year analysis in a tertiary hospitalRiccardo Bollini, Davide F Bavaro, Francesco De Fazio, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 10, 2025
A randomized, phase III study of sacituzumab govitecan versus treatment of the physician's choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)Ramez N Eskander, Bradley Corr, David Cibula, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 5, 2025
The virulence toolkit of Staphylococcus aureus: a comprehensive review of toxin diversity, molecular mechanisms, and clinical implicationsStefano Di Bella, Bruna Marini, Giacomo Stroffolini, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2014
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniaeMario Tumbarello, Enrico Maria Trecarichi, Fabio Tumietto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2020
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective StudyMichele Bartoletti, Renato Pascale, Monica Cricca, et al.
Science Advances|November 13, 2024
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activityAnna Nespolo, Linda Stefenatti, Ilenia Pellarin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 27, 2025
The impact of body mass index on survival and surgical outcomes in ovarian cancer: insights from the MITO trialsTeresa Di Lauro, Ilaria De Benedictis, Paolo Chiodini, et al.
Journal of Global Antimicrobial Resistance|January 13, 2025
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern ItalyValeria Cento, Sara Carloni, Riccardo Sarti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 21, 2022
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant EnterobacteralesMichele Bartoletti, Alberto Antonelli, Linda Bussini, et al.
Pageof 21

Showing results (151-160 of 209) with videos related to

Sort By:
Pageof 21
Gynecologic Oncology|March 25, 2023
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trialLucia Musacchio, Margherita Turinetto, Laura Arenare, et al.
Antimicrobial Resistance and Infection Control|May 11, 2026
Clinical and cost benefit of rapid molecular screening for carbapenem-resistant organisms: a seven-year analysis in a tertiary hospitalRiccardo Bollini, Davide F Bavaro, Francesco De Fazio, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 10, 2025
A randomized, phase III study of sacituzumab govitecan versus treatment of the physician's choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)Ramez N Eskander, Bradley Corr, David Cibula, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 5, 2025
The virulence toolkit of Staphylococcus aureus: a comprehensive review of toxin diversity, molecular mechanisms, and clinical implicationsStefano Di Bella, Bruna Marini, Giacomo Stroffolini, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2014
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniaeMario Tumbarello, Enrico Maria Trecarichi, Fabio Tumietto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2020
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective StudyMichele Bartoletti, Renato Pascale, Monica Cricca, et al.
Science Advances|November 13, 2024
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activityAnna Nespolo, Linda Stefenatti, Ilenia Pellarin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 27, 2025
The impact of body mass index on survival and surgical outcomes in ovarian cancer: insights from the MITO trialsTeresa Di Lauro, Ilaria De Benedictis, Paolo Chiodini, et al.
Journal of Global Antimicrobial Resistance|January 13, 2025
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern ItalyValeria Cento, Sara Carloni, Riccardo Sarti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 21, 2022
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant EnterobacteralesMichele Bartoletti, Alberto Antonelli, Linda Bussini, et al.
Pageof 21